These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 33014154)
1. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications. Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53. Wu M; Li X; Huang W; Chen Y; Wang B; Liu X Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946 [TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis Guo J; Wang M; Wang JP; Wu CX World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of differentially expressed genes reveals the promotive effects of UBE2T on colorectal cancer cell proliferation. Luo M; Zhou Y Oncol Lett; 2021 Oct; 22(4):714. PubMed ID: 34457069 [TBL] [Abstract][Full Text] [Related]
5. Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer. Zhu X; Li T; Niu X; Chen L; Ge C Oncol Lett; 2020 Oct; 20(4):44. PubMed ID: 32802166 [TBL] [Abstract][Full Text] [Related]
6. Role of ubiquitin-conjugating enzyme E2T in the carcinogenesis and progression of pancreatic cancer. Zheng YW; Gao PF; Ma MZ; Chen Y; Li CY Oncol Lett; 2020 Aug; 20(2):1462-1468. PubMed ID: 32724389 [TBL] [Abstract][Full Text] [Related]
7. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma. Zhu J; Ao H; Liu M; Cao K; Ma J J Transl Med; 2021 Aug; 19(1):374. PubMed ID: 34461934 [TBL] [Abstract][Full Text] [Related]
8. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma. Wang X; Liu Y; Leng X; Cao K; Sun W; Zhu J; Ma J Pathol Oncol Res; 2021; 27():632531. PubMed ID: 34257599 [No Abstract] [Full Text] [Related]
9. High ubiquitin conjugating enzyme E2 T mRNA expression and its prognostic significance in lung adenocarcinoma: A study based on the TCGA database. Wu ZH; Zhang YJ; Sun HY Medicine (Baltimore); 2020 Jan; 99(4):e18543. PubMed ID: 31977847 [TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression. Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression. Ren X; Li A; Ying E; Fang J; Li M; Yu J Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686 [TBL] [Abstract][Full Text] [Related]
12. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602 [TBL] [Abstract][Full Text] [Related]
13. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53. Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368 [TBL] [Abstract][Full Text] [Related]
14. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT. Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994 [TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-conjugating enzyme E2T promotes tumor stem cell characteristics and migration of cervical cancer cells by regulating the GRP78/FAK pathway. Liu Y; Ji W; Yue N; Zhou W Open Life Sci; 2021; 16(1):1082-1090. PubMed ID: 34703898 [TBL] [Abstract][Full Text] [Related]
16. UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells. Gong YQ; Peng D; Ning XH; Yang XY; Li XS; Zhou LQ; Guo YL Oncol Lett; 2016 Dec; 12(6):4485-4492. PubMed ID: 28101210 [TBL] [Abstract][Full Text] [Related]
17. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma. Hao P; Kang B; Li Y; Hao W; Ma F Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma. Xu F; Xiong N; Yuan Y; Liu J J Oncol; 2022; 2022():5244820. PubMed ID: 36245987 [TBL] [Abstract][Full Text] [Related]
19. Increased Expression of Zou R; Xu H; Li F; Wang S; Zhu L DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631 [TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers. Perez-Peña J; Corrales-Sánchez V; Amir E; Pandiella A; Ocana A Sci Rep; 2017 Dec; 7(1):17530. PubMed ID: 29235520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]